CNBX PHARMACEUTICALS INC. Foreign Currency Transaction Gain (Loss), before Tax
CNBX PHARMACEUTICALS INC. (CNBX) reported Foreign Currency Transaction Gain (Loss), before Tax of $2.10 thousand for the 12-month period ending 2025-08-31, per its 10-K filed 2025-12-01.
Financial Statements › Income Statement › Other Income
us-gaap:ForeignCurrencyTransactionGainLossBeforeTax · last filed 2025-12-01
- CNBX PHARMACEUTICALS INC. foreign currency transaction gain (loss), before tax for fiscal 2025 was $2.10K, a 40.34% decline from fiscal 2024.
- CNBX PHARMACEUTICALS INC. foreign currency transaction gain (loss), before tax for fiscal 2024 was $3.51K.
- CNBX PHARMACEUTICALS INC. foreign currency transaction gain (loss), before tax for fiscal 2023 was -$3.36K, a 105.74% decline from fiscal 2022.
- CNBX PHARMACEUTICALS INC. foreign currency transaction gain (loss), before tax for fiscal 2022 was $58.57K, a 166.41% increase from fiscal 2021.
| Period end | Foreign Currency Transaction Gain (Loss), before Tax 12 month |
|---|---|
| 2025-08-31 | $2.10K 10-K · filed 2025-12-01 |
| 2024-08-31 | $3.51K 10-K · filed 2025-12-01 |
| 2023-08-31 | -$3.36K 10-K · filed 2024-11-29 |
| 2022-08-31 | $58.57K 10-K · filed 2023-11-30 |
| 2021-08-31 | $21.98K 10-K · filed 2022-11-30 |
| 2020-08-31 | $62.85K 10-K · filed 2021-11-29 |
| 2019-08-31 | -$18.23K 10-K · filed 2020-11-04 |